Jeffrey C. Pepe - Net Worth and Insider Trading

Jeffrey C. Pepe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey C. Pepe owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .

Click here to see the complete history of Jeffrey C. Pepe’s form 4 insider trades.

Insider Ownership Summary of Jeffrey C. Pepe

Ticker Comapny Transaction Date Type of Owner
SBTX Silverback Therapeutics Inc 2022-09-02 Interim CEO and GC
SPRY ARS Pharmaceuticals Inc 2022-09-02 Interim CEO and GC

Jeffrey C. Pepe Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey C. Pepe Ownership Network

Ownership Network List of Jeffrey C. Pepe

No Data

Ownership Network Relation of Jeffrey C. Pepe

Insider Network Chart

Jeffrey C. Pepe Owned Company Details

What does Silverback Therapeutics Inc do?

Who are the key executives at Silverback Therapeutics Inc?

Jeffrey C. Pepe is the Interim CEO and GC of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .

Silverback Therapeutics Inc (SBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Silverback Therapeutics Inc Insider Transactions

No Available Data

Jeffrey C. Pepe Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey C. Pepe. You might contact Jeffrey C. Pepe via mailing address: C/o Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle Wa 98109.